H.C. Wainwright Reiterates Buy Rating on Definium Therapeutics Inc (DFTX)

April 24, 2026 6:41 AM

H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $70.00 price target on Definium Therapeutics Inc (NASDAQ: DFTX).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found